APA (7th ed.) Citation

J, O., Y, G., CY, G., EG, S., MI, Z., AB, R., . . . MA, L. (2025). Expression of Oct3/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia. Biomedical reports, 23(4), 164. https://doi.org/10.3892/br.2025.2042

Chicago Style (17th ed.) Citation

J, Organista-Nava, et al. "Expression of Oct3/4 Isoforms and Its Association with the Risk of Relapse in Acute Lymphoblastic Leukemia." Biomedical Reports 23, no. 4 (2025): 164. https://doi.org/10.3892/br.2025.2042.

MLA (9th ed.) Citation

J, Organista-Nava, et al. "Expression of Oct3/4 Isoforms and Its Association with the Risk of Relapse in Acute Lymphoblastic Leukemia." Biomedical Reports, vol. 23, no. 4, 2025, p. 164, https://doi.org/10.3892/br.2025.2042.